Vicus Capital Takes $205,000 Position in The Clorox Company (NYSE:CLX)

Vicus Capital bought a new position in The Clorox Company (NYSE:CLX) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 1,503 shares of the company’s stock, valued at approximately $205,000.

Other institutional investors and hedge funds have also modified their holdings of the company. Venturi Wealth Management LLC boosted its holdings in shares of Clorox by 308.5% in the 1st quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after acquiring an additional 145 shares in the last quarter. Northwest Financial Advisors acquired a new position in shares of Clorox in the 4th quarter worth approximately $29,000. GoalVest Advisory LLC acquired a new position in shares of Clorox in the 1st quarter worth approximately $31,000. First Foundation Advisors acquired a new position in shares of Clorox in the 1st quarter worth approximately $31,000. Finally, Core Wealth Advisors Inc. acquired a new position in shares of Clorox in the 4th quarter worth approximately $29,000. 78.53% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have issued reports on CLX shares. DA Davidson reduced their price objective on Clorox from $162.00 to $153.00 and set a “neutral” rating on the stock in a report on Friday, August 2nd. Evercore ISI reduced their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating on the stock in a report on Wednesday, May 1st. Argus raised Clorox to a “hold” rating in a report on Tuesday, June 4th. Citigroup reduced their price objective on Clorox from $150.00 to $145.00 and set a “neutral” rating on the stock in a report on Wednesday, July 10th. Finally, TD Cowen started coverage on Clorox in a report on Tuesday, July 23rd. They set a “sell” rating and a $122.00 price objective on the stock. Six equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the stock. According to data from MarketBeat, Clorox has a consensus rating of “Hold” and a consensus price target of $141.94.

Clorox Trading Up 0.5 %

Shares of CLX traded up $0.72 during trading hours on Thursday, reaching $151.34. The stock had a trading volume of 129,240 shares, compared to its average volume of 1,254,442. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $158.89. The firm has a 50-day moving average of $137.59 and a 200 day moving average of $142.42. The company has a market cap of $18.79 billion, a P/E ratio of 78.01, a P/E/G ratio of 1.97 and a beta of 0.39.

Clorox Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.22%. The ex-dividend date is Tuesday, August 13th. This is a boost from Clorox’s previous quarterly dividend of $1.20. Clorox’s dividend payout ratio is 252.85%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.